Upcoming Event: Compliance & Financial Reporting for the Pharmaceutical/ Biotechnology Industries in Asia Pacific 2008
2/13/2008
Event: Compliance & Financial Reporting for the Pharmaceutical/Biotechnology Industries in Asia Pacific 2008
Dates: May 29 - 30, 2008
Venue: Marina Mandarin Singapore, Singapore
This is a conference not to be missed! This conference on Compliance & Financial Reporting for the Pharmaceutical/ Biotechnology Industries in Asia Pacific 2008 is the first of its kind in Asia and will be held in Singapore from 29th – 30th May 2008.
Global markets are demanding international consistency in accounting and auditing standards and approaches. Several countries have either adopted IFRS or are basing their local standards on IFRS. The SEC has also voted recently to remove the requirement for non-US companies reporting under IFRS to reconcile their financial statements to US generally accepted accounting principles (GAAP). What is the implication of this trend on the pharmaceutical market?
With new rules by the US on pharmaceutical sales and marketing reporting compliance, questions have arisen as to what are the best practices for reporting and maintaining transparency to the public.
The CFO's role has evolved dramatically over the recent years in response to the changing external environment. CFOs are increasingly challenged to balance the changing demands yet at the same time maintain high performance standards.
The agenda for this conference aims to address all these issues and more.
CFRP 2008 will attract key players in the pharmaceutical and biotechnology industries from all over Asia Pacific and is designed for CFOs, chief accounting officers, controllers and accountants, treasurers, tax directors, compliance directors, internal auditors, accounting and risk managers, investor relations, general counsel, and regulatory affairs directors.
Among the key issues to be addressed are:
- Current Challenges in Financial Reporting
- Valuing Pharmaceutical Intangibles
- Accounting for Share-Based Payments and Other Compensation Issues
- Best Practices in Strategic Deals and Collaborations
- New Regulations and its Implications on Sales and Marketing Reporting Compliance
- Tax and Transfer Pricing Strategy Issues
- The Changing CFO Role
- A Risk Centric Internal Audit Model
- Anti-Fraud, Programs and Controls
- Securities and Shareholder Liability Risk Issues
- Latest Developments in China and India
- Using Compliance Management to Overcome Financial and Reputation Risks
- IFRS as a Strategic Opportunity
- Integrating the Financial and Non-Financial Metrics
- Outlook and Challenges for the Future